Surveillance studies: How can they help the management of infection?

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue TOPIC T2, 2000, Pages 53-58

  Masterton, R G ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEROPENEM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; CLINICAL PROTOCOL; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; DRUG SENSITIVITY; DRUG SURVEILLANCE PROGRAM; DRUG USE; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INTERNATIONAL COOPERATION; MEDICAL SERVICE; METHODOLOGY; NONHUMAN; PRACTICE GUIDELINE; QUALITY CONTROL; STANDARDIZATION; WORLD HEALTH ORGANIZATION;

EID: 0033833125     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/46.suppl_2.53     Document Type: Article

References (32)

1. Resisting resistance
2. The Alexander project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections
3. The emergent needs for basic research, education and surveillance of antimicrobial resistance. Problems facing the report from the American society for microbiology task force on antibiotic resistance
4. Report of the ASM task force on antibiotic resistance
5. Comparison of activities of broadspectrum β-lactam compounds against 1,128 Gram-positive cocci recently isolated in cancer treatment centers
6. β-Lactam resistance surveillance in the Asia-Western pacific region
7. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe 1997-1998
8. Antimicrobial resistance in key bloodstream bacterial isolates: Electronic surveillance with the surveillance network database-USA
9. Surveillance of resistance against antimicrobial agents: A European prospective
10. Nosocomial bloodstream infections in United States hospitals: A three-year analysis
11. Surveillance for the emergence and dissemination of antimicrobial resistance in bacteria
12. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE Phase 2
13. Nosocomial infections in medical intensive care units in the United States
14. United States geographic bacteria susceptibility patterns
15. The MYSTIC (meropenem yearly susceptibility test information collection) programme
16. Reports on surveillance of antimicrobial resistance in individual countries
17. Survey of bloodstream infections attributable to Gram-positive cocci: Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada and Latin America from the surveillance program
18. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998
19. Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY antimicrobial surveillance program (1997)
20. Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada and the United States
21. Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America
22. Surveillance of antimicrobial resistance: The WHONET program
23. European Surveillance of Antibiotic Resistance (ESAR), a European commission funded project
24. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program
25. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens-findings of the Alexander project 1992-1996
26. Effect of antibiotic use and other risk factors on antimicrobial resistance in pneumococci
27. Drug resistance in tuberculosis